Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-869-7 | CAS number: 13014-24-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 1989-January 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 1,2-dichloro-4-(trichloromethyl)benzene
- EC Number:
- 235-869-7
- EC Name:
- 1,2-dichloro-4-(trichloromethyl)benzene
- Cas Number:
- 13014-24-9
- Molecular formula:
- C7H3Cl5
- IUPAC Name:
- 1,2-dichloro-4-(trichloromethyl)benzene
- Details on test material:
- - Name of test material (as cited in study report): 3,4-Dichlorbenzotrichlorid
- Substance type: intermediate for synthesis
- Physical state: liquid, clear, colourless
- Analytical purity: 99.3%
- Purity test date: 23 March 1989
- Lot/batch No.: 16001/89
- Expiration date of the lot/batch: 23 September 1989
- Storage condition of test material: dark, room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Winkelmann, Borchen
- Age at study initiation: males: 7-8 weeks, females: 10-12 weeks
- Weight at study initiation: males: 168-188 g, females: 172-192 g
- Housing: Makrolon cages, type III, 5 animals per cage
- Diet (e.g. ad libitum): Altromin 1324 ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 °C
- Humidity (%): 50%
- Air changes (per hr): 10 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hours light 12 hours dark
IN-LIFE DATES: From: 10 May 1989 To: 13 June 1989
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Chromophor EL solution (2% v/v) in deionised water
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg bw
MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg bw - Doses:
- 1000, 1600 and 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: weekly
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, histopathology, behavioural observation
Results and discussion
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 424 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 065 - < 1 905
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 600 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 1000 mg/kg bw: males: 20%, females: 0%
16000 mg/kg bw: males: 60%, females: 40%
2000 mg/kg bw: males: 80%, females: 100% - Clinical signs:
- other: Apathy, reduced motility, spastic walking, respiratory difficulty, body weight loss, reflex reduction, contraction, reclined position, salivation, bloody eyes, urination increase, bloody urine, paleness, cramp and in one case hypothermy.
- Gross pathology:
- Lung dilatation, pale or coloured liver, pale spleen, pale or grey kidney with deformed structure, reddish pelvis, reddish stomach walls, thickened or thinned and with ulceration, bladder containing urine from clear to reddish, hard fecesl in the colon, small intestine with dark mucus.
Any other information on results incl. tables
Toxicological results on male rats
Dose (mg/kg) |
Toxicological results* |
Duration of signs |
Time of death |
Mortality (%) |
1000 |
1/5/5 |
15’-7 d |
7 d |
20 |
1600 |
3/5/5 |
40’- 12 d |
2-5 d |
60 |
2000 |
4/5/5 |
35 '-7 d |
1-6 d |
80 |
Toxicological results on female rats
Dose (mg/kg) |
Toxicological results* |
Duration of signs |
Time of death |
Mortality (%) |
1000 |
0/5/5 |
45’-7 d |
- |
0 |
1600 |
2/5/5 |
20’- 11 d |
3-10 d |
40 |
2000 |
5/5/5 |
30'- 11 d |
6-11 d |
100 |
Notes:
* 1st figure= number of dead animals
2nd figure= number of animals with symptoms
3rd figure= number of treated animals
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 4 based on CLP criteria
- Conclusions:
- The LD50 in male rat is 1424 mg/kg bw.
The LD50 in female rat is 1600 mg/kg bw. - Executive summary:
A toxicity study in which Wistar rats (5 males and 5 females/dose) received a single oral administration of the test article 3,4 -Dichlorbenzotrichloride at the doses of 1000, 1600 and 2000 mg/kg bw was conducted.
The test method was in accordance with OECD Guideline n. 401. The test article was administered in a Chromophor solution (2% v/v) in deionised water at the volume of 10 mL/kg bw .
The animals were weighed before treatment and on days 4, 8 and 14. They were clinically observed for 14 days after treatment.Animals which died and animals killed at the end of the study were submitted to a thorough autopsy. One male treated at 1000 mg/kg bw died on day 7. No female treated at 1000 mg/kg bw died on day 7. Three males treated at 1600 mg /kg bw died within days 2 and 5. At the same dose, 2 females died within days 3 and 10. Four males treated at 2000 mg/ kg bw died within day 1 and 6. At the same dose, 5 females died within day 6 and 11 of treatment.
Treated animals showed the following symptoms: lung dilatation, pale or coloured liver, pale spleen, pale or grey kidney with deformed structure, reddish pelvis, reddish stomach walls, thickened or thinned and with ulceration, bladder containing urine from clear to reddish, hard fecesl in the colon, small intestine with dark mucus. Recovery of all surviving rats was achieved from 15 minutes to 12 days. On days 4 and 8, significant body weight loss in some of the animals was registered, then recovered after the first or the second week of application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
